Petragen: Novel Therapeutics for Periodontal Disease
Lkit Therapeutics: Exploiting Synethtic Lethality to Target p53 Mutant Cancers Using First-In-Class Potent and Selective Small Molecule Inhibitors of Lipid Kinases PI5P4Kα/β.
Thyron Pharmaceuticals
Novel RNA Therapeutics that Target RIG-I
Proprietary Renalas Plaform: A First-In Class Renalas Agonist for Hyper-inflammation in Systemic Viral Infections, COVID-19, Acute Organ Injury
